Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03926299Completed
Randomised, open-label trial in vulvar lichen sclerosus (LS) (2 arms). Primary endpoint: Clinical Lichen sclerosus score at 6 months. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03926299.